| Identification | Back Directory | [Name]
(+)-Talarozole | [CAS]
201410-66-4 | [Synonyms]
(+)-TALAROZOLE
2-Benzothiazolamine, N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-, (+)- | [Molecular Formula]
C21H23N5S | [MOL File]
201410-66-4.mol | [Molecular Weight]
377.51 |
| Chemical Properties | Back Directory | [Boiling point ]
561.0±60.0 °C(Predicted) | [density ]
1.26±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: ≥ 72 mg/mL (190.72 mM) | [form ]
Solid | [pka]
2.70±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. | [Definition]
ChEBI:N-{4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine is a member of the class of benzothiazoles that is 2-amino-1,3-benzothiazole in which one of the amino hydrogens is replaced by a 4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl group. It is a member of triazoles, a member of benzothiazoles, an aromatic amine and a secondary amino compound. | [storage]
Store at -20°C | [References]
[1] Marc Gaston Venet, et al. N-[4-(heteroarylmethyl)phenyl]-heteroarylamines. WO 1997049704 A1. |
|
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|